CTCBIO Inc. (KOSDAQ:060590)

Dialog Axiata Revenue

CTCBIO had revenue of 34.44B KRW in the quarter ending March 31, 2026, with 16.94% growth. This brings the company's revenue in the last twelve months to 128.76B, up 6.09% year-over-year. In the year 2025, CTCBIO had annual revenue of 123.77B with 3.25% growth.

• Revenue (ttm): 128.76B
• Revenue Growth: +6.09%
• P/S Ratio: 0.61
• Revenue / Employee: 519.19M
• Employees: 248
• Market Cap: 78.30B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	123.77B	3.89B	3.25%
Dec 31, 2024	119.88B	-18.00B	-13.06%
Dec 31, 2023	137.88B	-27.33B	-16.54%
Dec 31, 2022	165.21B	24.89B	17.74%
Dec 31, 2021	140.32B	10.29B	7.91%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 7, 2026

Data Sources Report a data error